Matches in Wikidata for { <http://www.wikidata.org/entity/Q82204930> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q82204930 description "article scientifique (publié 2010)" @default.
- Q82204930 description "articolo scientifico (pubblicato il 2010)" @default.
- Q82204930 description "artikull shkencor i botuar më 01 janar 2010" @default.
- Q82204930 description "artículu científicu espublizáu en xineru de 2010" @default.
- Q82204930 description "im Januar 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82204930 description "scientific article published on 01 January 2010" @default.
- Q82204930 description "wetenschappelijk artikel" @default.
- Q82204930 description "наукова стаття, опублікована в січні 2010" @default.
- Q82204930 name "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 name "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 name "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 type Item @default.
- Q82204930 label "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 label "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 label "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 prefLabel "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 prefLabel "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 prefLabel "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 P1433 Q82204930-44B6294A-1911-4D2D-A82E-5B7F0CF2A5B9 @default.
- Q82204930 P1476 Q82204930-C851E1D0-9299-407F-A94C-A65974F54D72 @default.
- Q82204930 P2093 Q82204930-124B9B7B-4258-4565-942F-8B37739F20D7 @default.
- Q82204930 P2093 Q82204930-2409F42E-77C5-49CB-8632-3DF967ACA2D1 @default.
- Q82204930 P2093 Q82204930-31358CE0-3BD6-446F-967C-617188844F8E @default.
- Q82204930 P2093 Q82204930-6FF85295-8ABD-4956-90D2-B1F461776EFA @default.
- Q82204930 P2093 Q82204930-AFE83CC6-4453-4722-96C9-0ED3762080CF @default.
- Q82204930 P2093 Q82204930-E2094421-9E54-490A-BA66-9202A5D2BC70 @default.
- Q82204930 P2093 Q82204930-FD8FBFD7-6FE9-4FF8-98F1-01512E83AFF4 @default.
- Q82204930 P304 Q82204930-BD535EE2-FB0D-4AD9-9C28-577B7512EFE7 @default.
- Q82204930 P31 Q82204930-23077636-07BA-42AF-BE55-75FA5E71BF08 @default.
- Q82204930 P356 Q82204930-5D3BEAED-3FB1-4D68-8034-37622480A9B7 @default.
- Q82204930 P433 Q82204930-31ECBC7E-F804-44EF-99F8-2308A8C04D18 @default.
- Q82204930 P478 Q82204930-8CC5D24F-1764-424D-B010-9614EDB631D7 @default.
- Q82204930 P50 Q82204930-ACA312F9-A840-4874-9266-5728E68D161A @default.
- Q82204930 P577 Q82204930-C3BB4181-DA5C-4956-AEEA-5337EC162B25 @default.
- Q82204930 P698 Q82204930-A89A7119-A3BA-4915-AA98-E284156FA366 @default.
- Q82204930 P921 Q82204930-6C0F2A5E-4A62-4DBC-9CE8-D65E413F16FA @default.
- Q82204930 P921 Q82204930-EFA0790A-9A5C-42FE-94EE-28C16EF5E51D @default.
- Q82204930 P921 Q82204930-F511BEE2-6C67-4A45-8390-B7B56E9CE83E @default.
- Q82204930 P356 10428190903402029 @default.
- Q82204930 P698 20001240 @default.
- Q82204930 P1433 Q6534493 @default.
- Q82204930 P1476 "Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab" @default.
- Q82204930 P2093 "Blandine Fabre" @default.
- Q82204930 P2093 "Bruno Bonaz" @default.
- Q82204930 P2093 "Dimitri Salameire" @default.
- Q82204930 P2093 "Olivier Epaulard" @default.
- Q82204930 P2093 "Philippe Gaulard" @default.
- Q82204930 P2093 "Stéphane Courby" @default.
- Q82204930 P2093 "Virginie Hincky-Vitrat" @default.
- Q82204930 P304 "174-177" @default.
- Q82204930 P31 Q13442814 @default.
- Q82204930 P356 "10.3109/10428190903402029" @default.
- Q82204930 P433 "1" @default.
- Q82204930 P478 "51" @default.
- Q82204930 P50 Q62669287 @default.
- Q82204930 P577 "2010-01-01T00:00:00Z" @default.
- Q82204930 P698 "20001240" @default.
- Q82204930 P921 Q18939 @default.
- Q82204930 P921 Q412323 @default.
- Q82204930 P921 Q6900 @default.